Literature DB >> 28875436

Predictors of Daily Pain Medication Use in Individuals with Recurrent Back Pain.

John A Sturgeon1, Jennifer M Hah2, Yasamin Sharifzadeh2, Stephanie K Middleton2, Thomas Rico2, Kevin A Johnson2, Sean C Mackey2.   

Abstract

PURPOSE: A key component to chronic pain management regimens is the use of analgesic medications. Psychological factors, such as mood states, may also affect the use of pain medications for individuals with chronic pain, but few observational studies have examined how these factors may predict pain medication use at the daily level.
METHODS: Daily assessments from 104 individuals with back pain were used to examine fluctuations in daily pain intensity, mood, sleep quality, and physical activity as predictors of the likelihood of pain medication (opioid and non-opioid) use and levels of medication use on the same day.
RESULTS: Pain intensity and mood ratings significantly predicted whether participants used pain medication on the same day, while only pain intensity predicted whether participants used more medication than usual. Further, current opioid users were more likely to increase the amount of their medication use on days of higher pain. DISCUSSION: This article identifies fluctuations in daily pain intensity and mood as salient predictors of daily pain medication use in individuals with recurrent back pain. The current study is among the first to highlight both pain and mood states as predictors of daily pain medication use in individuals with back pain, though future studies may expand on these findings through the use of higher-resolution daily medication use variables.

Entities:  

Keywords:  Daily diaries; Medication use; Mood; Opioid medications; Pain intensity

Mesh:

Substances:

Year:  2018        PMID: 28875436      PMCID: PMC5837935          DOI: 10.1007/s12529-017-9686-8

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  26 in total

1.  Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.

Authors:  Alicia Grattan; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Michael R Von Korff
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Depressive symptoms during buprenorphine treatment of opioid abusers.

Authors:  T R Kosten; C Morgan; T A Kosten
Journal:  J Subst Abuse Treat       Date:  1990

4.  Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria.

Authors:  Joseph A Boscarino; Margaret R Rukstalis; Stuart N Hoffman; John J Han; Porat M Erlich; Stephen Ross; Glenn S Gerhard; Walter F Stewart
Journal:  J Addict Dis       Date:  2011 Jul-Sep

5.  Drug abuse as self-medication for depression: an empirical study.

Authors:  R D Weiss; M L Griffin; S M Mirin
Journal:  Am J Drug Alcohol Abuse       Date:  1992       Impact factor: 3.829

6.  Can End-of-day reports replace momentary assessment of pain and fatigue?

Authors:  Joan E Broderick; Joseph E Schwartz; Stefan Schneider; Arthur A Stone
Journal:  J Pain       Date:  2008-12-13       Impact factor: 5.820

7.  Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy.

Authors:  Marc O Martel; Patrick H Finan; R Kathryn McHugh; Mohammed Issa; Robert R Edwards; Robert N Jamison; Ajay D Wasan
Journal:  Drug Alcohol Depend       Date:  2016-03-18       Impact factor: 4.492

8.  Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients.

Authors:  Laura L Adams; Robert J Gatchel; Richard C Robinson; Peter Polatin; Noor Gajraj; Martin Deschner; Carl Noe
Journal:  J Pain Symptom Manage       Date:  2004-05       Impact factor: 3.612

9.  Cerebral metabolism and mood in remitted opiate dependence.

Authors:  Igor I Galynker; Daniel Eisenberg; John A Matochik; Enid Gertmenian-King; Lisa Cohen; Alane S Kimes; Carlo Contoreggi; Varughese Kurian; Monique Ernst; Richard N Rosenthal; James Prosser; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2007-05-22       Impact factor: 4.492

10.  A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain.

Authors:  Beatrice Setnik; Carl L Roland; Kenneth W Sommerville; Glenn C Pixton; Robert Berke; Anne Calkins; Veeraindar Goli
Journal:  J Pain Res       Date:  2015-07-09       Impact factor: 3.133

View more
  4 in total

1.  Associations of mental health and family background with opioid analgesic therapy: a nationwide Swedish register-based study.

Authors:  Patrick D Quinn; Martin E Rickert; Johan Franck; Amir Sariaslan; Katja Boersma; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  Pain       Date:  2019-11       Impact factor: 7.926

2.  Comparative efficacy of a single-session "Empowered Relief" videoconference-delivered group intervention for chronic pain: study protocol for a randomized controlled trial.

Authors:  Maisa S Ziadni; Steven R Anderson; Lluvia Gonzalez-Castro; Beth D Darnall
Journal:  Trials       Date:  2021-05-22       Impact factor: 2.279

3.  The Effectiveness of Thermal Neuromodulation Using Precise Heat in the Treatment of Chronic Low Back Pain Over 60 Days: An In-Home User Trial.

Authors:  Jenny E Hapgood; Charles Chabal; Peter J Dunbar
Journal:  J Pain Res       Date:  2021-09-07       Impact factor: 3.133

4.  Efficacy and mechanisms of a single-session behavioral medicine class among patients with chronic pain taking prescription opioids: study protocol for a randomized controlled trial.

Authors:  Maisa S Ziadni; Abby L Chen; Tyler Winslow; Sean C Mackey; Beth D Darnall
Journal:  Trials       Date:  2020-06-12       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.